Morgan Stanley Reaffirms Their Hold Rating on Ascendis Pharma (ASND)
In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a ...
Zymeworks (ZYME) Gets a Hold from Wells Fargo
In a report released today, Derek Archila from Wells Fargo maintained a Hold rating on Zymeworks (ZYME – Research Report), with a price target ...
Yahoo Finance5d
Ascendis Pharma A/S (ASND)
COPENHAGEN, Denmark, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the TD Cowen 45th Annual ...
pharmaphorum5d
Novo puts $285m into monthly GLP-1 based on Ascendis tech
Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist. The Danish pharma ...
Bloomberg L.P.3d
Ascendis Pharma A/S
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Yahoo Finance6d
Ascendis Pharma A/S (ASND)
After hours: 7:21:52 p.m. EST Loading Chart for ASND ...
Yahoo Finance6d
Ascendis Pharma A/S (ASND)
After hours: 7 March at 7:21:52 pm GMT-5 Loading Chart for ASND ...
Seeking Alpha1d
ASND Ascendis Pharma A/S
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The ...